In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
In the latest session, Dyne Therapeutics Inc (NASDAQ: DYN) closed at $10.86 down -21.42% from its previous closing price of $13.82. In other words, the price has decreased by -$21.42 from its previous closing price. On the day, 6.69 million shares were traded.
Ratios:
For a deeper understanding of Dyne Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 20.35 and its Current Ratio is at 20.35. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
On May 29, 2025, Evercore ISI started tracking the stock assigning a Outperform rating and target price of $46.Evercore ISI initiated its Outperform rating on May 29, 2025, with a $46 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 11 ’25 when Scalzo Richard William bought 1,330 shares for $14.75 per share.
Beskrovnaya Oxana bought 2,132 shares of DYN for $31,449 on Jun 11 ’25. On Jun 05 ’25, another insider, Cox John, who serves as the CEO & President of the company, sold 4,060 shares for $13.35 each. As a result, the insider received 54,201 and left with 142,179 shares of the company.
Stock Price History:
Over the past 52 weeks, DYN has reached a high of $47.45, while it has fallen to a 52-week low of $6.36. The 50-Day Moving Average of the stock is -3.77%, while the 200-Day Moving Average is calculated to be -47.34%.
Shares Statistics:
A total of 113.63M shares are outstanding, with a floating share count of 85.23M. Insiders hold about 25.01% of the company’s shares, while institutions hold 83.74% stake in the company.
